The Treatment of Periappendicular Abscess After the Acute Phase
PeriAPPAC
1 other identifier
interventional
110
0 countries
N/A
Brief Summary
The PeriAPPAC trial is a prospective randomised study comparing interval laparoscopic appendectomy with follow-up MRI in patients with initially successfully treated periappendicular abscess. Periappendicular abscess is generally initially treated conservatively with antibiotic therapy and if necessary, drainage. Operative treatment in the acute abscess phase is associated with increased morbidity and thus complicated appendicitis with a periappendicular abscess is initially treated conservatively. However, there is debate on whether interval appendectomy is required. After initial successful conservative treatment of a CT- or MRI-diagnosed periappendicular abscess, patients enrolled in the PeriAPPAC study are randomised either to interval appendectomy or to follow-up with MRI at two months after the initial treatment. All patients also undergo a colonoscopy, appendectomy patients prior to surgery and MRI patients after the MRI (outpatient visit at endoscopy unit with information on the MRI). The primary endpoint is the treatment success in both treatment arms. In the interval appendectomy evaluated as possible morbidity related to appendectomy and in the follow-up treatment arm as possible recurrence of the appendicitis and/or abscess during a one-year follow-up. The PeriAPPAC study is a multi centre trial and the participating hospitals are Turku University Hospital, Oulu University Hospital, Tampere University Hospital, Kuopio University Hospital and Seinäjoki Central Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2013
CompletedFirst Submitted
Initial submission to the registry
August 19, 2016
CompletedFirst Posted
Study publicly available on registry
January 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
ExpectedNovember 12, 2020
November 1, 2020
4.7 years
August 19, 2016
November 10, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Treatment success
Treatment success in both treatment arms. In the interval appendectomy evaluated as possible morbidity related to appendectomy and successful appendectomy and in the follow-up treatment arm as possible recurrence of the appendicitis and/or abscess during a one-year follow-up
One year after the intervention
Secondary Outcomes (7)
Possible appendiceal or colon tumours
1-10 years
Possible diagnosis of Crohn's disease
1-10 years
The length of hospital stay
up to one year
Sick leave
up to one year
Overall morbidity
Up to 10 years, time points 1, 3, 5 and 10 years
- +2 more secondary outcomes
Study Arms (2)
Interval Appendectomy
ACTIVE COMPARATORThe periappendicular abscess, diagnosed by a CT-scan or MRI, is initially treated conservatively with antibiotic therapy and with drainage, if necessary. Interval appendectomy is performed at two months after the primary treatment, all patients also undergo colonoscopy prior to appendectomy.
Follow-up with MRI
ACTIVE COMPARATORThe periappendicular abscess, diagnosed by a CT-scan or MRI, is initially treated conservatively with antibiotic therapy and with drainage, if necessary. The patients undergo abdominal magnetic resonance imaging at two months after the primary treatment, all patients also undergo colonoscopy right after the MRI.
Interventions
Eligibility Criteria
You may qualify if:
- Age 18-60 years
- CT- or MRI-diagnosed periappendicular abscess, that has initially undergone successful conservative treatment with antibiotic therapy and drainage, if necessary
You may not qualify if:
- Suspicion of a tumour on CT or MRI
- Age under 18 years or over 60 years
- Pregnancy or lactating
- Allergy to contrast media or iodine
- Renal insufficiency
- Metformin medication (DM)
- Unsuccessful initial conservative treatment of periappendicular abscess
- Lack of co-operation (unable to give consent)
- A severe medical condition
- Previous acute appendicitis treated conservatively with antibiotics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Turku University Hospitallead
- Oulu University Hospitalcollaborator
Related Publications (1)
Mallinen J, Rautio T, Gronroos J, Rantanen T, Nordstrom P, Savolainen H, Ohtonen P, Hurme S, Salminen P. Risk of Appendiceal Neoplasm in Periappendicular Abscess in Patients Treated With Interval Appendectomy vs Follow-up With Magnetic Resonance Imaging: 1-Year Outcomes of the Peri-Appendicitis Acuta Randomized Clinical Trial. JAMA Surg. 2019 Mar 1;154(3):200-207. doi: 10.1001/jamasurg.2018.4373.
PMID: 30484824DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paulina Salminen, MD, PhD
Turku University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
August 19, 2016
First Posted
January 6, 2017
Study Start
January 15, 2013
Primary Completion
September 30, 2017
Study Completion (Estimated)
December 31, 2030
Last Updated
November 12, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share